[Interventional treatment of biliary liver disease]

Zhonghua Gan Zang Bing Za Zhi. 2022 Jul 20;30(7):685-689. doi: 10.3760/cma.j.cn501113-20220430-00231.
[Article in Chinese]

Abstract

Biliary liver diseases such as intrahepatic cholangiocarcinoma and primary biliary cholangitis seriously endanger the health of patients. Interventional treatments such as hepatic arterial infusion chemotherapy and transjugular intrahepatic portosystemic shunt have the advantages of less surgical trauma, faster recovery, and lower cost than conventional internal medicine and surgical treatments. Thus, they are widely used in biliary liver diseases. This article reviews the interventional treatment of common biliary liver diseases, in an attempt to provide reference for the corresponding clinical diagnosis, treatment and research.

肝内胆管细胞癌、原发性胆汁性胆管炎等胆源性肝脏疾病严重危害患者健康。相较于常规内外科治疗方式,介入治疗,如肝动脉灌注化学治疗、经颈静脉肝内门体分流术等,具有创伤小、恢复快、费用低等优势,已在该领域获得广泛应用。现对常见胆源性肝脏疾病的介入治疗进行综述,为相应的临床诊治及研究提供参考。.

Publication types

  • Review

MeSH terms

  • Biliary Tract*
  • Hepatic Encephalopathy*
  • Humans
  • Liver Diseases*
  • Portasystemic Shunt, Transjugular Intrahepatic*